CIK 0001737953
- Non-accelerated filer
- Smaller reporting company
Replimune Group, Inc.
Sign in to watch- Ticker
- REPL
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Mar 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 822082553
- Phone
- +1 781-222-9600
- Business address
- 500 UNICORN PARK, WOBURN, MA, 01801
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $521,860
- in 2 filings
Net −$521,860. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 83 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-08-10 | Patel Sushil Chief Executive Officer | Sale | −39,341 | $12.97 | $510K | 708,151 |
| 2026-05-18 | Patel Sushil Chief Executive Officer | Sale | −37,324 | $5.08 | $190K | 747,492 |
| 2026-04-01 | Patel Sushil Chief Executive Officer | Grant or award | +251,240 | 784,816 | ||
| 2026-04-01 | Patel Sushil Chief Executive Officer | Grant or award · Employee Stock Option (right to buy) | +376,860 | 376,860 | ||
| 2025-12-19 | Patel Sushil Chief Executive Officer | Grant or award | +200,000 | 533,576 | ||
| 2025-12-02 | Patel Sushil Chief Executive Officer | Sale 10b5-1 | −10,000 | $11.13 | $111K | 333,576 |
| 2025-05-20 | Patel Sushil Chief Executive Officer | Sale | −25,105 | $8.06 | $202K | 343,576 |
| 2025-04-01 | Patel Sushil Chief Executive Officer | Grant or award | +166,667 | 368,681 | ||
| 2025-04-01 | Patel Sushil Chief Executive Officer | Grant or award · Employee Stock Option (right to buy) | +250,000 | 250,000 | ||
| 2024-12-16 | Patel Sushil Chief Executive Officer | Sale 10b5-1 | −10,000 | $12.42 | $124K | 202,014 |
| 2024-05-16 | Patel Sushil Chief Executive Officer | Sale | −20,194 | $6.47 | $131K | 212,014 |
| 2024-04-01 | Patel Sushil Chief Executive Officer | Grant or award | +83,335 | 232,208 | ||
| 2024-04-01 | Patel Sushil Chief Executive Officer | Grant or award · Employee Stock Option (right to buy) | +250,000 | 250,000 | ||
| 2023-06-13 | Patel Sushil Chief Strategy Officer | Sale 10b5-1 | −5,145 | $24.11 | $124K | 149,426 |
| 2023-06-13 | Patel Sushil Chief Strategy Officer | Sale 10b5-1 | −553 | $23.44 | $13K | 148,873 |
| 2023-05-16 | Patel Sushil Chief Strategy Officer | Sale | −15,575 | $18.05 | $281K | 154,571 |
| 2023-04-01 | Patel Sushil Chief Strategy Officer | Grant or award | +40,000 | 170,146 | ||
| 2023-04-01 | Patel Sushil Chief Strategy Officer | Grant or award · Employee Stock Option (right to buy) | +60,000 | 60,000 | ||
| 2022-05-16 | Patel Sushil Chief Commercial Officer | Sale | −10,687 | $14.59 | $156K | 130,146 |
| 2022-04-01 | Patel Sushil Chief Commercial Officer | Grant or award | +52,500 | 140,833 |
Page 1 of 2 · 23 trades